General MedicationsORALStandard
VERSACLOZ
CLOZAPINE
Standard Dose
50MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview VERSACLOZ is listed in Drugs@FDA under application 203479 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient CLOZAPINE Form and strength SUSPENSION;ORAL - 50MG/ML Sponsor DOUGLAS PHARMS Submission history Latest submission status date: 2025-06-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview VERSACLOZ is listed in Drugs@FDA under application 203479 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient CLOZAPINE Form and strength SUSPENSION;ORAL - 50MG/ML Sponsor DOUGLAS PHARMS Submission history Latest submission status date: 2025-06-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.